IRIS
GIANNONI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.050
AS - Asia 13.001
EU - Europa 11.916
SA - Sud America 2.826
AF - Africa 333
Continente sconosciuto - Info sul continente non disponibili 302
OC - Oceania 31
Totale 50.459
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.808
SG - Singapore 4.721
RU - Federazione Russa 3.449
CN - Cina 3.132
IT - Italia 2.844
BR - Brasile 2.214
VN - Vietnam 1.801
GB - Regno Unito 1.752
BD - Bangladesh 954
HK - Hong Kong 921
CA - Canada 862
DE - Germania 838
UA - Ucraina 627
FR - Francia 439
SE - Svezia 434
IN - India 274
DK - Danimarca 271
FI - Finlandia 269
NL - Olanda 228
AR - Argentina 222
MX - Messico 219
IE - Irlanda 189
PL - Polonia 179
IL - Israele 176
TR - Turchia 159
ID - Indonesia 137
EC - Ecuador 126
ES - Italia 114
JP - Giappone 113
IQ - Iraq 109
PK - Pakistan 109
ZA - Sudafrica 105
AT - Austria 71
CO - Colombia 61
MA - Marocco 61
UZ - Uzbekistan 60
VE - Venezuela 58
AE - Emirati Arabi Uniti 42
CL - Cile 42
LT - Lituania 41
PH - Filippine 37
MY - Malesia 35
PY - Paraguay 33
SA - Arabia Saudita 32
KE - Kenya 31
TN - Tunisia 28
EG - Egitto 27
EU - Europa 27
JM - Giamaica 26
NP - Nepal 26
PE - Perù 25
CR - Costa Rica 24
HN - Honduras 24
UY - Uruguay 23
CH - Svizzera 21
RO - Romania 21
BE - Belgio 19
DZ - Algeria 18
AU - Australia 17
JO - Giordania 17
AZ - Azerbaigian 16
TH - Thailandia 15
PT - Portogallo 14
BO - Bolivia 13
KG - Kirghizistan 13
NI - Nicaragua 13
GR - Grecia 12
KR - Corea 12
PS - Palestinian Territory 12
DO - Repubblica Dominicana 11
SV - El Salvador 11
GT - Guatemala 10
TT - Trinidad e Tobago 10
NZ - Nuova Zelanda 9
CZ - Repubblica Ceca 8
PA - Panama 8
TW - Taiwan 8
BG - Bulgaria 7
ET - Etiopia 7
HU - Ungheria 7
KZ - Kazakistan 7
LY - Libia 7
OM - Oman 7
SI - Slovenia 7
AO - Angola 6
BB - Barbados 6
BH - Bahrain 6
CI - Costa d'Avorio 6
GE - Georgia 6
IR - Iran 6
MD - Moldavia 6
MG - Madagascar 6
QA - Qatar 6
AL - Albania 5
CG - Congo 5
GD - Grenada 5
GY - Guiana 5
HR - Croazia 5
MT - Malta 5
NO - Norvegia 5
Totale 50.075
Salva come PNG Salva come JPEG
Città #
Dallas 3.731
Singapore 2.363
Ashburn 1.632
San Jose 1.436
Beijing 1.245
Southend 907
Hong Kong 802
Chandler 734
Los Angeles 660
Council Bluffs 608
Moscow 595
Fairfield 585
Houston 555
Ho Chi Minh City 535
Woodbridge 471
Chicago 450
New York 439
San Mateo 436
Ann Arbor 422
Milan 422
Falls Church 406
Seattle 372
Hanoi 364
Cambridge 334
Jacksonville 334
Wilmington 326
The Dalles 304
Santa Clara 297
Rome 290
Ottawa 257
Buffalo 255
São Paulo 240
Boardman 232
Lauterbourg 224
Hefei 215
Dearborn 214
Dublin 187
Salt Lake City 183
Pisa 180
Portsmouth 170
Stevenage 164
Beauharnois 163
Orem 156
Warsaw 154
Tel Aviv 152
Dong Ket 147
Munich 146
Helsinki 141
London 138
Lawrence 133
Montreal 132
Brooklyn 125
Phoenix 120
Mexico City 113
Atlanta 102
Denver 102
Tokyo 99
Florence 91
Stockholm 91
Toronto 91
Frankfurt am Main 88
Chennai 85
Poplar 85
Tampa 84
Elk Grove Village 75
Istanbul 75
Amsterdam 74
Da Nang 72
Montréal 72
Johannesburg 71
Rio de Janeiro 71
Nuremberg 70
Figino 67
San Diego 65
Haiphong 61
Boston 58
Tashkent 55
Fremont 53
San Francisco 51
Turin 51
Columbus 50
Naples 50
Manchester 49
Guayaquil 48
Ankara 47
Bologna 47
Biên Hòa 43
Brasília 42
Miami 41
Mumbai 41
Turku 41
Lappeenranta 40
Redwood City 40
Belo Horizonte 39
Paris 37
Quito 37
Washington 37
Dongguan 36
Genoa 36
Baghdad 35
Totale 29.191
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.711
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 632
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 520
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 458
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 403
A simple echocardiographic score to rule out cardiac amyloidosis 396
A simple echocardiographic score to rule out cardiac amyloidosis 382
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 363
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 357
Central sleep apnea and cardiovascular disease state-of-the-art 354
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 351
[Central apneas and cardiovascular diseases] 346
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 344
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 344
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 337
Etiology, clinical presentation, and management of left main coronary artery aneurysms 336
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 336
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 336
Prediction of the chemoreflex gain by common clinical variables in heart failure 334
Treating chemoreflex in heart failure: modulation or demolition? 329
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 324
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 323
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 322
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 321
Adrenergic activation in heart failure: blockade or rebalance? 316
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 309
Eligibility for vericiguat in a real‐world, contemporary heart failure population 309
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 309
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 308
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 307
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 305
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 301
Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential 299
Screening the health status of people working in a university 297
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 296
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 296
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 296
How to take arms against central apneas in heart failure 291
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 286
Diaphragm function does not independently predict exercise intolerance in patients with precapillary pulmonary hypertension after adjustment for right ventricular function 285
Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure 282
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 281
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 278
Central And Obstructive Apneas in Heart Failure With Reduced, Mid-Range And Preserved Ejection Fraction. 278
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 277
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 272
A Novel Homozygous Mutation of the Desmoplakin Gene With Biventricular Arrhythmogenic Cardiomyopathy 272
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 271
Models of BOLD Signal Change in Breath Hold Studies and CO2 Challenges: Methodological Issues and Interpretation 271
Contribution of the lung to the genesis of cheyne-stokes respiration in heart failure: Plant gain beyond chemoreflex gain and circulation time 271
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 270
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 269
Effects of nasal high flow on sympathovagal balance, sleep, and sleep-related breathing in patients with precapillary pulmonary hypertension 269
Improved survival in limited scleroderma-related pulmonary artery hypertension 268
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 268
Unveiling a sudden unexplained death case by whole exome sequencing and bioinformatic analysis 268
Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan 265
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones 265
B-type natriuretic peptide secretion following scuba diving 263
Valve disease in cardiac amyloidosis: an echocardiographic score 262
APAP therapy does not improve impaired sleep quality and sympatho-vagal balance: a randomized trial in patients with obstructive sleep apnea and systolic heart failure 262
Correlational analysis of electroencephalographic and end-tidal carbon dioxide signals during breath-hold exercise 259
null 258
null 258
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 257
A Novel Workflow for Electrophysiology Studies in Patients with Brugada Syndrome 256
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease 255
null 253
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register 252
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 252
Prognostic value of right ventricular refractory period heterogeneity in Type-1 Brugada electrocardiographic pattern 252
An atypical case of cardiac amyloidosis. 250
Mapping dependencies of BOLD signal change to end-tidal CO2: Linear and nonlinear modeling, and effect of physiological noise correction 250
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 249
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 248
In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation 248
Heart Failure Results in Inspiratory Muscle Dysfunction Irrespective of Left Ventricular Ejection Fraction 246
Role of Imaging in Cardiomyopathies 245
Renin profiling predicts neurohormonal response to sacubitril/valsartan 245
Chemoreflex and Baroreflex Sensitivity Hold a Strong Prognostic Value in Chronic Heart Failure 244
High-risk NSTEMI due to subclavian artery atherothrombosis in a prior coronary artery bypass graft patient 244
Autonomic and respiratory consequences of altered chemoreflex function: clinical and therapeutic implications in cardiovascular diseases 243
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction 243
Effects of hyperventilation length on muscle sympathetic nerve activity in healthy humans simulating periodic breathing 243
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 242
A scoping review of machine learning models to predict risk of falls in elders, without using sensor data 242
Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients. 242
Changes in chemoreflex characteristics following acetazolamide administration in patients with chronic heart failure and Cheyne Stokes respiration 241
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? 241
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea 239
Ld-EEG Effective Brain Connectivity in Patients With Cheyne-Stokes Respiration 236
Inspiratory muscle dysfunction and restrictive lung function impairment in congenital heart disease: Association with immune inflammatory response and exercise intolerance 235
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry 234
Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure. 234
Impact of Simulated Hyperventilation and Periodic Breathing on Sympatho-Vagal Balance and Hemodynamics in Patients with and without Heart Failure 233
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 232
Breathless heart: only when the neck is deep in water? 231
On the Use of Linear-Modelling-based Algorithms for Physiological Noise Correction in fMRI Studies of the Central Breathing Control 231
Diagnosis of preclinical /mild heart failure with B-type natriuretic peptides: compariosn betwwen BNP and NT-proBNP immunoassay methods 230
null 228
Totale 30.272
Salva come PNG Salva come JPEG
Categoria #
all - tutte 248.293
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 248.293
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.799 0 0 113 278 71 43 239 431 151 247 55 171
2022/20231.643 133 154 83 209 220 243 17 143 253 32 81 75
2023/20241.162 107 34 280 90 37 88 80 49 30 39 39 289
2024/202510.624 65 80 466 207 596 585 1.383 2.351 871 919 1.973 1.128
2025/202625.926 1.343 3.988 2.900 3.612 2.928 1.598 2.381 1.034 1.384 1.546 1.706 1.506
2026/20271.827 752 799 276 0 0 0 0 0 0 0 0 0
Totale 50.459